Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)

Market Cap	9.54B +151.2%
Revenue (ttm)	1.39B -13.3%
Net Income	14.20M -86.1%
EPS	0.03 -82.3%
Shares Out	611.69M
PE Ratio	671.87
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,589,800
Average Volume	17,418,050
Open	15.46
Previous Close	15.60
Day's Range	15.41 - 15.88
52-Week Range	4.82 - 18.28
Beta	0.91
RSI	49.73
Earnings Date	Apr 25, 2026

About SHE:002082

Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through two segments, the Pharmaceutical Business and the Medical Device Business. It offers drugs products used to treat cardiovascular and cerebrovascular diseases; and nervous, respiratory, mental, and digestive system diseases. The company also develops and sells orthopedic implant devices, including...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 1,499
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002082

Financial Performance

In 2024, SHE:002082's revenue was 1.44 billion, a decrease of -6.39% compared to the previous year's 1.54 billion. Earnings were 55.44 million, an increase of 12.66%.